Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes
Article in Cancer Research and Treatment (August 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort
Article in British Journal of Clinical Pharmacology (June 2023)
Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co‐Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer
Article in Clinical Pharmacology & Therapeutics (April 2023)